OBJECTIVE: To examine the association between retinopathy and cognitive decline or brain lesions and volumes in older women. METHODS: This study included 511 women aged 65 and older who were simultaneously enrolled in the Women's Health Initiative Memory Study and the Sight Examination Study. In this analysis, we examined the link between retinopathy, assessed using fundus photography (2000-2002), cognitive performance over time assessed by the modified Mini-Mental State Examination (3MSE) (1996-2007), and white matter hyperintensities and lacunar infarcts in the basal ganglia. RESULTS: Presence of retinopathy was associated with poorer 3MSE scores (mean difference = 1.01, SE: 0.43) (p = 0.019) over a 10-year follow-up period and greater ischemic volumes in the total brain (47% larger, p = 0.04) and the parietal lobe (68% larger, p = 0.01) but not with measures of regional brain atrophy. CONCLUSIONS: The correspondence we found between retinopathy and cognitive impairment, along with larger ischemic lesion volumes, strengthens existing evidence that retinopathy as a marker of small vessel disease is a risk factor for cerebrovascular disease that may influence cognitive performance and related brain changes. Retinopathy may be useful as a clinical tool if it can be shown to be an early marker related to neurologic outcomes.
OBJECTIVE: To examine the association between retinopathy and cognitive decline or brain lesions and volumes in older women. METHODS: This study included 511 women aged 65 and older who were simultaneously enrolled in the Women's Health Initiative Memory Study and the Sight Examination Study. In this analysis, we examined the link between retinopathy, assessed using fundus photography (2000-2002), cognitive performance over time assessed by the modified Mini-Mental State Examination (3MSE) (1996-2007), and white matter hyperintensities and lacunar infarcts in the basal ganglia. RESULTS: Presence of retinopathy was associated with poorer 3MSE scores (mean difference = 1.01, SE: 0.43) (p = 0.019) over a 10-year follow-up period and greater ischemic volumes in the total brain (47% larger, p = 0.04) and the parietal lobe (68% larger, p = 0.01) but not with measures of regional brain atrophy. CONCLUSIONS: The correspondence we found between retinopathy and cognitive impairment, along with larger ischemic lesion volumes, strengthens existing evidence that retinopathy as a marker of small vessel disease is a risk factor for cerebrovascular disease that may influence cognitive performance and related brain changes. Retinopathy may be useful as a clinical tool if it can be shown to be an early marker related to neurologic outcomes.
Authors: Joshua A Sonnen; Eric B Larson; Paul K Crane; Sebastien Haneuse; Ge Li; Gerald D Schellenberg; Suzanne Craft; James B Leverenz; Thomas J Montine Journal: Ann Neurol Date: 2007-10 Impact factor: 10.422
Authors: Sarah A Jaramillo; Deborah Felton; Leeann Andrews; Lisa Desiderio; Rose K Hallarn; Sharon D Jackson; Laura H Coker; Jennifer G Robinson; Judith K Ockene; Mark A Espeland Journal: Acad Radiol Date: 2007-05 Impact factor: 3.173
Authors: Tien Yin Wong; Ronald Klein; A Richey Sharrett; David J Couper; Barbara E K Klein; Duan-Ping Liao; Larry D Hubbard; Thomas H Mosley Journal: JAMA Date: 2002-07-03 Impact factor: 56.272
Authors: Tien Y Wong; Ronald Klein; F M Amirul Islam; Mary Frances Cotch; David J Couper; Barbara E K Klein; Larry D Hubbard; A Richey Sharrett Journal: Am J Ophthalmol Date: 2007-04-02 Impact factor: 5.258
Authors: Chengxuan Qiu; Mary Frances Cotch; Sigurdur Sigurdsson; Melissa Garcia; Ronald Klein; Fridbert Jonasson; Barbara E K Klein; Gudny Eiriksdottir; Tamara B Harris; Mark A van Buchem; Vilmundur Gudnason; Lenore J Launer Journal: Diabetes Date: 2008-03-10 Impact factor: 9.461
Authors: S M Resnick; M A Espeland; S A Jaramillo; C Hirsch; M L Stefanick; A M Murray; J Ockene; C Davatzikos Journal: Neurology Date: 2009-01-13 Impact factor: 9.910
Authors: Karen L Margolis; Robert Brzyski; Denise E Bonds; Barbara V Howard; Sarah Kempainen; Jennifer G Robinson; Monika M Safford; Lesley T Tinker; Lawrence S Phillips Journal: Clin Trials Date: 2008 Impact factor: 2.486
Authors: Thasarat Sutabutr Vajaranant; Joelle Hallak; Mark A Espeland; Louis R Pasquale; Barbara E Klein; Stacy M Meuer; Stephen R Rapp; Mary N Haan; Pauline M Maki Journal: Am J Ophthalmol Date: 2019-06-01 Impact factor: 5.258
Authors: Rachael S Allen; Adam M Hanif; Marissa A Gogniat; Brian C Prall; Raza Haider; Moe H Aung; Megan C Prunty; Lukas M Mees; Monica M Coulter; Cara T Motz; Jeffrey H Boatright; Machelle T Pardue Journal: Eur J Neurosci Date: 2018-04-03 Impact factor: 3.386
Authors: Laura H Coker; Mark A Espeland; Patricia E Hogan; Susan M Resnick; R Nick Bryan; Jennifer G Robinson; Joseph S Goveas; Christos Davatzikos; Lewis H Kuller; Jeff D Williamson; Cheryl D Bushnell; Sally A Shumaker Journal: Neurology Date: 2014-01-02 Impact factor: 9.910
Authors: Thomas C Hanff; A Richey Sharrett; Thomas H Mosley; Dean Shibata; David S Knopman; Ronald Klein; Barbara E K Klein; Rebecca F Gottesman Journal: Stroke Date: 2014-02-18 Impact factor: 7.914
Authors: Sophie M Heringa; Willem H Bouvy; Esther van den Berg; Annette C Moll; L Jaap Kappelle; Geert Jan Biessels Journal: J Cereb Blood Flow Metab Date: 2013-04-17 Impact factor: 6.200
Authors: Liora G Rodill; Lieza G Exalto; Paola Gilsanz; Geert Jan Biessels; Charles P Quesenberry; Rachel A Whitmer Journal: Alzheimer Dis Assoc Disord Date: 2018 Apr-Jun Impact factor: 2.703